Navigation Links
Deadly Diarrhoea Vaccine – Trail Results Promising

Diarrhoea is a major cause of morbidity and mortality in India. An attempt to formulate// a vaccine against this deadly disease, which has claimed so many young lives, is worth the expense.

India is set to begin the phase II clinical trials of a new vaccine for a deadly form of diarrhoea that causes thousands of deaths annually in India. This move has been accelerated after phase I clinical trials showed up to 70 percent success among adults, children and infants. If the phase II trials are materialized, it is likely to yield more conclusive results towards complete protection from the disease.

The rotaviral diarrhoea contributes 40 percent of the dehydrating diarrhoea disease in infants and young children, causing 150,000 deaths annually in India, which proves that the investment is worthy.

The trial concentrated on the safety and immunogenicity of the two vaccines. The results revealed that the 116E based vaccine is safe and provides up to 70 percent protection with single dose in infants, which may increase to complete protection with two to three doses.

The phase II trial of the 116E vaccine is scheduled to be conducted in New Delhi.

Source:IANS

Medindia on Diarrhoea: Replacement of fluids and electrolytes (salts and minerals) lost due to diarrhoea is the main aim. Self-treatment includes avoiding dehydration by drinking lots of electrolyte solutions that are available in all pharmacies and are dispensed without a prescription.

More on Medindia:

http://www.medindia.net/patients/
PatientInfo/salmonellosis.asp

'"/>




Page: 1

Related medicine news :

1. Smoking and Breast Cancer - A Deadly Combination
2. Latest Findings On The Deadly Disease - SARS
3. Sharp Increase Of The Deadly Diseases In Delhi
4. Imported Plants Could Deadly Harbor Mosquitoes, Says Report
5. Deadly Kiss - Peanut allergy kills a teenager
6. Deadly abortion pill takes two more lives
7. Severe Urinary Infection Could Lead To Deadly Blood Clots
8. Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh
9. New Vaccine To Combat The Deadly Marburg Virus
10. Smoking and Obesity- A Deadly Combination
11. Tobacco Deadly In Any Form
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the United ... persecution, Center for Medicine after the Holocaust (CMATH) announced that it will ... and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany and ...
(Date:4/24/2017)... ... , ... Today, Bright Pink , a national non-profit organization focusing on the prevention and ... , Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. ... as Chairman of the Board and launched a national search to find a visionary ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
(Date:4/24/2017)... ... 2017 , ... The world-class designers of Happy Gadget Alert ... lifesaving device for the everyday use of parents worldwide. It is a lightweight, ... a child’s vital signs, and detect unusual symptoms or physical patterns. This innovative ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: